The ever growing amount of new substances released onto the market and the limited predictability of current in vitro test systems has led to a high need for new solutions for substance testing. Many drugs that have been removed from the market due to drug-induced liver injury released their toxic potential only after several doses of chronic testing in humans. However, a controlled microenvironment is pivotal for longterm multiple dosing experiments, as even minor alterations in extracellular conditions may greatly influence the cell physiology. We focused within our research program on the generation of a microengineered bioreactor, which can be dynamically perfused by an on-chip pump and combines at least two culture spaces for multi-organ applications. This circulatory system mimics the in vivo conditions of primary cell cultures better and assures a steadier, more quantifiable extracellular relay of signals to the cells.
Introduction
Current monolayer or suspension cell culture assays for drug development are failing to emulate the human cellular microenvironment and, therefore, lead to a rapid dedifferentiation and loss of function in primary human cell cultures. Tissue models with higher physiological relevance are needed to predict the efficacy and safety of compounds before admitting them to clinical trials. Recently, standard in vitro cell culture techniques have evolved from two-dimensional monolayer cultures toward three-dimensional multi-cellular models, aiming to mimic the in vivo tissue microenvironment. These systems have already shown major improvements towards more accurate prediction of the mode of action of compounds 1, 2 . Furthermore, adapting the in vitro culture conditions to the highly specialized needs of cells is of particular interest.
Under standard in vitro conditions, a variety of important culture parameters, such as nutrient and oxygen supply, removal of accumulating products, and mechanical force acting on the cells often cannot be controlled thoroughly in most cases. Many organs possess physiologically relevant concentration gradients of substances and dissolved oxygen. However, those highly regulated and optimized conditions are in clear opposition to the uncontrollable diffusion gradients around tissues under in vitro conditions, leading to a highly unstable environment and limiting cellular development 3 . Tissue-to-fluid ratios within these systems play an especially crucial role in simulating physiologically relevant cellular crosstalk. However, due to technical limitations, such as the use of external pumps and media reservoirs, the overall circulating media volume in most systems is too large compared to the tissue volumes. The group of Shuler et al. were the first to develop a system ensuring proper residence times of substances within the cell culture compartments and in vivo relevant tissue-to-fluid ratios 7, 8 . This was achieved by scaling the external reservoir down to a 96-well plate, also representing the "other tissues" compartment. In order to minimize the circulating media volume within our MOC platform, we integrated a peristaltic on-chip micropump, eliminating the need for external media circuits. This micropump is able to operate the system at a selectable number of media flow velocities and shear stress rates 9 . A microfluidic channel system of 500 µm width and 100 µm height interconnects two standardized tissue culture spaces, each having the size of a single well of a 96-well plate. Adhering to the sizes of industry standard well plates allows the integration of already existing tissue models produced in the transwell format. Furthermore, the vertical position of transwell cell culture inserts is adjustable, enabling the cultivation of tissue models which are not only directly exposed to the fluid flow, but can also be lifted up and shielded from the underlying current. Similarly, air-liquid interface cultures are feasible using this system. The MOC platform is fabricated from a polydimethylsiloxane (PDMS) layer 2 mm high and a glass microscope slide with a footprint of 75 x 25 mm 2 , which are permanently bonded by low pressure plasma oxidation to form the fluid-tight microfluidic circuit. The PDMS layer containing the respective channels and cell culture compartments is produced by standard soft lithography and replica molding 9 . The microfluidic design of the MOC used during this study consisted of two separate microfluidic circuits per chip, each holding two cell culture compartments interconnected by a channel system 100 µm high. This allowed the performance of two individual two-tissue cocultures using one multi-organ chip. Pumping frequencies were adjusted to yield medium flow rates of 40 µl/min. This two-tissue MOC design provided the capability to coculture a liver spheroid and a skin punch biopsy in separate culture spaces, albeit in a combined media circuit under physiological flow conditions. Differentiated HepaRG cells were aggregated together with human hepatic stellate cells (HHSteC) at a ratio of 24:1 to form homogenous spheroids. This ratio was found to be optimal, as observed in previous experiments 10 , even though, nearly twice the number of hepatocytes were used compared to the in vivo situation. The skin was cultivated at an air-liquid interface inside a transwell cell culture insert, thus enabling topical substance exposure. These tissue models were cocultivated for 28 days in the MOC to demonstrate the comprehensiveness of this system. Furthermore, the microfluidic channel circuit of the chips was fully covered with human dermal microvascular endothelial cells (HDMEC) to more closely simulate the vascular system.
Protocol
NOTE: Human juvenile prepuce was obtained with informed consent and ethics approval (Ethic Committee Charité University Medicine, Berlin, Germany), in compliance with the relevant laws, from a pediatric surgery after routine circumcisions.
Production of Tissue Equivalents for Cultivation in the MOC
1. Aggregate HepaRG and HHSteC in hanging drop plates to generate liver spheroids.
1. In order to achieve the trypsinization of HepaRG cells grown in cell culture flasks (75 cm 2 ), remove the medium from confluent, differentiated monolayer cultures, wash with PBS twice, and add 3 ml of 0.05% Trypsin/EDTA. Incubate for 3 to 5 min at 37 °C and stop the reaction by adding 6 ml of trypsin inhibitor. 2. Centrifuge HepaRG cells at 150 x g for 5 min, remove supernatant, resuspend the cell pellet in 1 ml of HepaRG cell culture medium, and count cells. Cell viability should be >90%. 3. In order to achieve the trypsinization of HHSteC cells, remove the medium from monolayer cultures, wash with PBS twice, and add 3 ml of 0.05% Trypsin/EDTA. Incubate for 5 min at 37 °C and stop the reaction by adding 6 ml of trypsin inhibitor. 4. Centrifuge the HHSteC cells at 150 x g for 5 min, remove supernatant, resuspend the cell pellet in 1 ml of HepaRG cell culture medium, and count cells. 6. Prepare a hanging drop plate by adding 2 ml of PBS to the hanging drop and receiver plate. 7. Pipette 20 µl of the cell suspension into each well of the hanging drop plate. Always prepare about 10% more hanging drops than you need to retrieve aggregates, as some aggregates are lost during the procedure. Carefully place the plate in a 37 °C incubator. Wait 48 hr for the spheroids to form. 8. In order to retrieve the spheroids, be sure to use pipette tips with wide tip endings or cut the tips of 1 ml pipette tips with a sterile knife in order to widen the opening to about 2 to 3 mm. Use these pipette tips to handle the spheroids without disrupting them. 9. Wash off spheroids carefully from the hanging drop plate by repeatedly adding 1 ml of media to the top of the wells of the hanging drop plate using a pipette. Wash the plate until all the spheroids have fallen off. Spheroids are slightly disc-shaped with a medium diameter of 300 to 400 µm and a height of 200 to 300 µm at this point. 10. Collect the spheroids in the receiver plate and transfer them to 24-well ultra-low attachment plates with a maximum of 20 spheroids per well using the prepared pipette tips. Adjust the media volumes in each well to 0.5 ml. Use 20 aggregates to inoculate one MOC circuit to obtain a miniaturization rate of 1/100,000 regarding in vivo cell numbers. 11. Incubate the spheroids at 37 °C and 5% CO 2 until further use in the MOC. Do not store the spheroids longer than three days before usage to assure comparability. Cultivate the aggregates for at least one day in ultra-low attachment plates to retrieve the homogenous spheroids.
2. Pursue either of two approaches to generate skin tissue equivalents: the use of punch biopsies (1.2.1) or the use of ready-made in vitro tissue models (1.3.1). 1. Cut transwells with an incandescent knife below the bracket to prepare 96-well cell culture inserts and store under sterile conditions until further use.
MOC Fabrication
1. Mix the PDMS and curing agent at a ratio of 10:1 (v/v) and place the mixture under vacuum for 15 min to remove air bubbles. 2. Meanwhile, treat a polycarbonate cover-plate with the silicon rubber additive at 80 °C for 20 min. 3. Insert Teflon screws into respective holes of the cover-plate to create the four PDMS-free cell culture compartments and the six PDMS membranes, 500 µm thick, of the micropump. 4. Plug the prepared cover-plate to the master mold of the two microvascular circuits and inject the degassed PDMS. Take care not to integrate air bubbles into the system. If bubbles emerge, try to remove them by tilting the device. 5. Incubate the system at 80 °C for 60 min to cure the PDMS layer. 6. Remove the master mold and the Teflon screws from the device and bond the PDMS layer to a glass slide with a 75 x 25 mm 2 footprint using low pressure plasma oxidation. 7. Screw special thread MOC adapters to all four cell culture compartments of the cover-plate. 8. Connect syringes containing culture medium to female Luer x ¼-28 male adapters and screw them to the MOC adapters of the cover-plate. 9. Inject the medium into the microfluidic circuit by repeatedly pushing down and pulling up the syringes plungers. 10. Check the proper filling of the channels with medium under the microscope.
Endothelialization of the MOC
1. Prior to endothelializing the MOC, flush each MOC circuit with endothelial cell growth medium and incubate it statically for three days at 37 °C and 5% CO 2 .
1. Sterilize the MOCs using an ethanol wipe and place them under a laminar flow bench. In addition, sterilize two pairs of forceps and two hexagonal keys for further use. 2. Loosen the caps of the tissue culture compartment of the MOC using the hexagonal keys and remove the caps using the forceps. After inserting the medium, screw caps back on to the MOCs in the same way.
2. In order to achieve the trypsinization of human dermal microvascular endothelial cells (HDMEC), remove the medium from the monolayer cultures, wash with PBS twice, and add 3 ml of 0.05% Trypsin/EDTA. Incubate for 5 min at 37 °C and stop the reaction by adding 6 ml of trypsin inhibitor. 3. Centrifuge the HDMEC at 220 x g for 5 min, remove supernatant, resuspend the cell pellet in 1 ml of endothelial cell growth medium, and count cells. Cell viability should be >90%. 4. Adjust the cell count in the cell suspension to a final concentration of 2 x 10 7 cells/ml by diluting it with endothelial cell growth medium and transfer 250 µl of it to a 1 ml syringe. Apply this concentration of cells to the MOC to keep the miniaturization rate of 1/100,000 for all organs. 5. Connect the syringe to a female Luer x ¼-28 male adapter, expel the air out of this fitting, and screw it to a special thread MOC adapter.
Connect the adapter to one of the two compartments of each MOC circuit. 6. Connect an empty syringe in the same way to the second compartment of the MOC circuit. 7. Inject the cells evenly by pushing down and pulling up the two syringe plungers several times in a consecutive way. Control the infusion of cells under the microscope. 8. Incubate the MOC at 37 °C and 5% CO 2 under static conditions for 3 hr to allow the cells to adhere to the channel walls. 9. Remove the chip from the incubator, place it under a laminar flow bench, and replace the syringes and the MOC adapters with special thread MOC cell culture chambers. 10. Add 400 µl of fresh medium to one compartment of each MOC circuit and let it flush through the channels by hydrostatic pressure.
Afterwards, replace the medium in both compartments with 300 µl of fresh medium. 11. Close the compartments using caps, as described in 3.1.2. 12. Connect the chip to the pump control unit. Adjust the pumping velocity to a frequency of 0.475 Hz and cultivate the chip at 37 °C and 5% CO 2 . 13. Replace the medium of each MOC compartment every one to two days and monitor the cell morphology by light microscopy.
Representative Results
Standard in vitro tissue cultures are performed under static conditions, limiting the diffusion of the oxygen and nutrient supply to the tissues. Fluidic systems, showing improved supply characteristics, are often hampered by their large medium requirements, having non-physiologically high medium to tissue ratios. Thus, metabolites are diluted and cells are not able to condition their surroundings. The MOC presented in this study connects two separate tissue culture compartments, each the size of a single well of a standard 96-well plate, by a microfluidic channel system. The small scale of the system and the integration of the pump on the chip allows the system to operate at media volumes of only 200 to 800 µl. This corresponds to a total systemic medium to tissue ratio of 8:1 to 31:1, respectively, for the liver and skin tissue cocultures (having a total tissue volume of about 26 µl). The total extra-cellular fluid volume in a man weighing 73 kg is 14.6 L, whereof the intercapillary fluid volume is 5.1 L, leading to a physiological extracellular fluid to tissue ratio of 1:4. Therefore, the amount of media in the whole circulation system in the MOC is still larger compared to the physiological situation; and yet, it represents the smallest media to tissue ratio reported so far for multiorgan systems 5 . As industry standard tissue culture formats are retained, researchers are able to combine existing and already validated static tissue models within a common fluid flow. Figure 1 shows the schematic of an experimental set-up of possible MOC single tissue or multitissue cocultures. Primary tissue biopsies and in vitro-generated tissue equivalents from cell lines or primary cells can be cultivated either using 96-well cell culture inserts or by placing them directly into the tissue culture compartments. As the channel system interconnecting the cell culture compartments is only 100 µm high, tissue equivalents exceeding these dimensions will be kept within the culture compartments. The endothelialization of the MOC circuit with primary HDMECs enables a further step forward towards more physiological culture conditions by providing a biological vascular structure. Following the endothelialization protocol, a confluent HDMEC coverage of the microfluidic channel circuit is obtained within four days of dynamic culture, as shown in Figure 2 . Cells readily adhere to the walls of the MOC channel, create a confluent monolayer, and elongate along the shear stress ( Figure 2B) . Furthermore, cells cover the entire circumference of the channels, as reported previously In a further experiment, consistent disk-shaped liver cell spheroids are formed from HepaRG and HHSteC during two days of hanging drop culture, as this model system was previously reported as being suitable for drug metabolism studies [11] [12] [13] . For demonstration purposes, one tissue culture compartment of each MOC circuit was seeded with 20 spheroids in 96-well cell culture inserts and tissues were cultivated over 14 days under dynamic conditions using non-endothelialized MOCs. Any number of aggregates or amount of primary material can be integrated either directly into the compartments or using cell culture inserts. Immunofluorescent staining of the spheroids after retrieval from the MOC shows a strong, homogenous expression for liver-typical cytokeratin 8/18 and phase I metabolizing enzymes cytochrome P450 3A4 and 7A1 ( Figure 3A and 3B) . Staining of canalicular transporter multi-drug resistance protein 2 (MRP-2) revealed a polarized phenotype and the existence of rudimentary bile canaliculi-like networks ( Figure 3C ). As the production of albumin is one essential prerequisite of liver tissue cultures, it has been selected to monitor liver-typical activity in the MOC. Analyzing daily media samples for albumin production shows a significant increase in production rate in MOC cultures compared to static cultures (Figure 4) and to values reported in literature Figure 6 : Performance of multi-tissue cultures over 28 days. Liver equivalents and skin biopsies were cultivated in an endothelialized MOC and cell functionality was shown by immunostaining of (A) Phase I enzymes cytochrome P450 3A4 (red), (B) vimentin (red), (C) cytokeratin 8/18 (red) and vWF (green) in liver tissue. Skin biopsies cocultivated for 28 days (D) in the MOC or (E) under static conditions were stained for tenascin c (red) and collagen IV (green), blue nuclear staining. (F) H&E staining of the skin after 28 days of MOC culture. Scale bars: 100 µm.
Discussion
The MOC platform described here represents a stable and powerful tool for cultivating tissues of various origins at dynamic medium flow conditions over prolonged culture periods 10, 16 . In this example, the platform was used to cultivate primary cells (HDMEC), tissue equivalents generated from a cell line (liver aggregates), and a coculture of the aforementioned with a tissue biopsy. The MOC was able to sustain the three-tissue coculture for up to 28 days in a combined medium circuit. To the best of the authors' knowledge, this is the first time a multi-tissue coculture including biopsies, primary cells and cell lines has been performed over four weeks.
One of the major drawbacks of microfluidic systems is the affinity of small molecules to adhere to the surface material of the fluidic circuit. As the surface to volume ratio is especially high in microfluidic systems, this effect becomes even more pronounced 17 . The stable HDMEC coverage of the channels, introduced here, might act as a biological barrier preventing the adhesion of molecules to the MOC. Furthermore, it may serve as a hemocompatible vessel for whole blood circulation, preventing blood clotting. However, the use of whole blood as a medium substitution is not feasible as a full vascularization of the organ equivalents has not yet been achieved. Existing work on the vascularization of in vitro-generated tissues is promising and guides the way for further studies 18, 19 .
It is well-known that hepatocytes tend to lose their liver-specific functions over time under static two-dimensional in vitro culture conditions 20 .
Metabolizing enzymes, such as the cytochrome P450 family, are of especial importance if the metabolism of a certain drug is to be studied. Cytochrome P450 3A4, an enzyme related to the biotransformation of many xenobiotics, and cytochrome P450 7A, which is involved in bile acid synthesis, were expressed in liver aggregates cultured in the MOC over 14 days. This indicates the preservation of a metabolically active phenotype, allowing for drug metabolism studies. The increased albumin production rate of aggregates in the MOC compared to static cultures is an additional indication for adequate culture conditions. The albumin production rates observed during this study were comparable or even higher than previously reported values obtained by microfluidic chips including HepG2 cells [21] [22] [23] , however, values did not reach those of primary human hepatocyte cultures 24 . Furthermore, the MOC system, in its temporary layout, does not allow for a separate segregation of bile. Cells in the aggregate polarized and formed bile canaliculi-like structures, as shown by MRP-2 staining. However, those canaliculi were not connected to a technical channel collecting the bile. This non-physiological mixing of the bile with the blood compartment has to be addressed in a future redesign of the system. The adjustment of flow characteristics is of high importance 25 , especially with regard to tissues sensitive to shear stress, such as the liver. The amount of shear stress perceived by the tissue can be modified in two ways: Firstly, the air pressure used to push down the membranes of the pump can be lowered, decreasing peak shear stress values in the system. Secondly, the tissues can be embedded in an extracellular matrix layering or cultured in transwell culture inserts. The latter shield the tissues from the underlying current with a porous membrane. These adjustments need to be performed on an individual basis for each organ equivalent before starting the MOC experiment. At a pulsatile operation of 2.4 Hz, for example, which corresponds to a high, but still physiological, heart activity of 144 beats/min in humans, the shear stress measured in the channels of the microvascular circuit reaches approximately 25 dyn/cm 2 . This corresponds to a physiological shear stress at the higher end of the scale in microvasculature and is, therefore, well applicable for experiments including an endothelialization of the channels. However, as the current microfluidic layout of the MOC system presented consists of only one media circuit connecting the two organ compartments, one pumping velocity and shear stress rate has to be chosen for the whole system. Therefore, an exact adjustment of flow characteristics to the needs of each single organ is not always feasible.
Furthermore, care has to be taken in adjusting the cells to the common medium. Cells are cultivated in the MOC in a combined media circuit, therefore, no individual cell culture media can be used for each tissue model, as is the standard for in vitro cell culture. A minimal combined media formulation needs to be defined beforehand and the cells need to be adjusted stepwise to this new media. An adjustment procedure of 80%/20% old to new media for two days, then 50%/50% followed by 20%/80%, and a full exchange always led to a reasonable cell viability and functionality of cultures in our hands.
The current microfluidic layout of the MOC system allows the coculture of up to three tissues. A coculture of at least the ten most important organs of the human body is needed to reach homeostasis. Therefore, the system presented is able to predict specific tissue-tissue interactions, but not the true systemic response to a substance. A further development of the MOC to include more organ cavities is envisaged. Moreover, the validity of the system is to be shown using a set of reference compounds. Preferably, compounds that have failed during clinical trials (such as Troglitazone) are to be tested for their performance in the MOC. Whereas, a true validation of such complex systems is still impeded by the lack of standardization concerning biomarkers and endpoints for functional evaluation, collecting more data on the toxicological performance of this and similar systems will broaden their reliability and area of application.
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